logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Return

TRISCEND II

delete2026-07-18
delete0
PRE
AI
A
Anna Sannino *
P
Paul A. Grayburn
S
Susheel K Kodali
P
Philipp Lurz
V
Vinod H. Thourani
M
Moody Makar
C
Christiane Haeffele
J
Jyothy Puthumana
J
James Lee
P
Peter Flueckiger
S
Scott Chadderdon
R
Ratnasari Padang
N
Nishant K. Sekaran
T
Terri Stewart-Dehner
J
Jörg Ender
K
Konstantinos Koulogiannis
M
Mohamed Morsy
R
Rhonda Miyasaka
B
Benjamin Havens
I
Ivy Ku
DOI：10.1016/j.jcmg.2026.05.019delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
The TRISCEND II (EVOQUE Transcatheter Tricuspid Valve Replacement: Pivotal Clinical Investigation of Safety and Clinical Efficacy Using a Novel Device) trial demonstrated clinical benefits for transcatheter tricuspid valve replacement (TTVR) with the EVOQUE system over medical therapy for the primary safety and effectiveness endpoint to 1 year.

Journal

J
JACC-Cardiovascular Imaging
IF:
15.2
Papers:
29
Citations:
0

Organization

No organization information available